(All committee members underwent the same ethics review and vetting process required of all FDA advisory committee members, Emily Hilliard, a spokesperson for the Department of Health and Human Services, told me in an email.) The decision is only a recommendation, and the FDA would still need to sign off on an actual rule change
If you are considering this peptide, it is worth knowing how supervised peptide therapy at our Doral clinic is structured and how this peptide fits into a broader, monitored plan
The skinny on these skinny shots
Because of that, there are inherent risks associated with purchasing them from unreputable sources
The labeling still carries the full weight of warnings from both drug classes (liver risk from acetaminophen, GI/cardiovascular risk from NSAIDs)a good reminder that "OTC" doesn't mean "no risk." I'm curious what others in the regulatory space thinkis this Rx-to-OTC trend something we'll see more of globally, including in India